Diagnosis of human herpes virus 1 and 2 (HHV-1 and HHV-2): use of a synthetic standard curve for absolute quantification by real time polymerase chain reaction.

Mem Inst Oswaldo Cruz

Fundação Oswaldo Cruz-Fiocruz, Instituto Oswaldo Cruz, Laboratório de Desenvolvimento Tecnológico em Virologia, Rio de Janeiro, RJ, Brasil.

Published: March 2017

AI Article Synopsis

Article Abstract

The use of quantitative real time polymerase chain reaction (qPCR) for herpesvirus detection has improved the sensitivity and specificity of diagnosis, as it is able to detect shedding episodes in the absence of clinical lesions and diagnose clinical specimens that have low viral loads. With an aim to improve the detection and quantification of herpesvirus by qPCR, synthetic standard curves for human herpesvirus 1 and 2 (HHV-1 and HHV-2) targeting regions gD and gG, respectively, were designed and evaluated. The results show that synthetic curves can replace DNA standard curves in diagnostic herpes qPCR.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5319368PMC
http://dx.doi.org/10.1590/0074-02760160354DOI Listing

Publication Analysis

Top Keywords

hhv-1 hhv-2
8
synthetic standard
8
real time
8
time polymerase
8
polymerase chain
8
chain reaction
8
standard curves
8
diagnosis human
4
human herpes
4
herpes virus
4

Similar Publications

Background: Approximately 2% of HerpeSelect herpes simples virus type 2 (HSV-2) IgG enzyme immunoassay (screen assay) sera-positive samples do not confirm using an HSV-2 IgG inhibition assay. Of these, roughly 1.33% are confirmed negative, and a small proportion (0.

View Article and Find Full Text PDF

Lack of Herpes Simplex Virus (HSV) vaccine, low vaccination rates of Influenza viruses, waning immunity and viral transmission after vaccination underscore the need to reduce viral loads at their transmission sites. Oral virus transmission is several orders of magnitude higher than nasal transmission. Therefore, in this study, we evaluated neutralization of viruses using a natural viral trap protein (FRIL) formulated in clinical-grade chewing gum.

View Article and Find Full Text PDF

Mechanisms of HSV gene regulation during latency and reactivation.

Virology

January 2025

State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China; Department of Medical Microbiology and Parasitology, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China. Electronic address:

Herpes simplex virus 1 and 2 (HSV-1 and HSV-2) are prevalent human pathogens associated with many diseases. After productive (lytic) infection in peripheral tissues, HSV establishes lifelong latent infection in neurons of the peripheral nervous system. Periodic reactivation from latency, triggered by certain stimuli, can resume the lytic cycle.

View Article and Find Full Text PDF

Mortality and prognosis in herpes simplex Virus-1 encephalitis long-term follow up study.

J Neurol Sci

January 2025

Department of Neurology, Rambam Medical Center, Haifa, Israel; AI in Neurology Laboratory, Ruth and Bruce Rapaport Faculty of Medicine, Technion Institute of Technology, Haifa 3525408, Israel; Department of Neurology, Mayo Clinic, Rochester, MN, United States of America. Electronic address:

Article Synopsis
  • Herpes simplex virus-1 (HSV-1) encephalitis is the most common type of viral encephalitis globally, but there is limited understanding of long-term mortality rates and influencing factors.
  • A retrospective study analyzed data from HSV-positive encephalitis patients over 23 years, finding that 55.31% of HSV-1 patients died during follow-up, with older age and cancer comorbidities significantly increasing mortality risk.
  • Key findings highlighted that older patients had a higher risk of death, and having cancer dramatically impacted mortality, with an optimal age cut-off of 63.29 years identified for predicting outcomes.
View Article and Find Full Text PDF

Genital herpes simplex virus (HSV) is associated with a reduction in quality of life and adverse outcomes. The aim of this study is to assess the interest and expectations for a therapeutic HSV vaccine among individuals diagnosed with genital herpes in Italy. A retrospective survey was conducted at the Infectious Diseases Unit of the IRCCS San Raffaele Scientific Institute, Milan, Italy.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!